These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine. Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046 [TBL] [Abstract][Full Text] [Related]
6. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model. Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218 [TBL] [Abstract][Full Text] [Related]
8. Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice. Yamagishi A; Ikekubo Y; Mishina M; Ikeda K; Ide S J Pharmacol Sci; 2024 Mar; 154(3):203-208. PubMed ID: 38395521 [TBL] [Abstract][Full Text] [Related]
9. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of ( Highland JN; Morris PJ; Zanos P; Lovett J; Ghosh S; Wang AQ; Zarate CA; Thomas CJ; Moaddel R; Gould TD J Psychopharmacol; 2019 Jan; 33(1):12-24. PubMed ID: 30488740 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Zhao X; Venkata SL; Moaddel R; Luckenbaugh DA; Brutsche NE; Ibrahim L; Zarate CA; Mager DE; Wainer IW Br J Clin Pharmacol; 2012 Aug; 74(2):304-14. PubMed ID: 22295895 [TBL] [Abstract][Full Text] [Related]
12. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses. Zanos P; Highland JN; Liu X; Troppoli TA; Georgiou P; Lovett J; Morris PJ; Stewart BW; Thomas CJ; Thompson SM; Moaddel R; Gould TD Br J Pharmacol; 2019 Jul; 176(14):2573-2592. PubMed ID: 30941749 [TBL] [Abstract][Full Text] [Related]
13. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Toki H; Yamaguchi JI; Mizuno-Yasuhira A; Endo H J Pharm Biomed Anal; 2023 Feb; 224():115168. PubMed ID: 36473323 [TBL] [Abstract][Full Text] [Related]
14. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184 [TBL] [Abstract][Full Text] [Related]
15. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Farmer CA; Gilbert JR; Moaddel R; George J; Adeojo L; Lovett J; Nugent AC; Kadriu B; Yuan P; Gould TD; Park LT; Zarate CA Neuropsychopharmacology; 2020 Jul; 45(8):1398-1404. PubMed ID: 32252062 [TBL] [Abstract][Full Text] [Related]
16. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray. Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886 [TBL] [Abstract][Full Text] [Related]
17. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model. Zhang K; Fujita Y; Hashimoto K Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385 [TBL] [Abstract][Full Text] [Related]
18. Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice. Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Igarashi H; Seiriki K; Nakazawa T; Kasai A; Ago Y; Hashimoto H J Pharmacol Sci; 2024 Feb; 154(2):72-76. PubMed ID: 38246730 [TBL] [Abstract][Full Text] [Related]
19. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model. Ju L; Yang J; Zhu T; Liu P; Yang J BMC Psychiatry; 2022 Mar; 22(1):182. PubMed ID: 35291971 [TBL] [Abstract][Full Text] [Related]
20. (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice. Yamaguchi JI; Toki H; Qu Y; Yang C; Koike H; Hashimoto K; Mizuno-Yasuhira A; Chaki S Neuropsychopharmacology; 2018 Aug; 43(9):1900-1907. PubMed ID: 29802366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]